Scar Dimensions and Area Conversions
The right hip scar measures 18 cm × 2.5 cm, and the keloid formation, hyperpigmentation, and abnormal texture each occupy less than 38.7 cm² (six square inches converted to metric).
Detailed Measurements
Linear Dimensions
- Scar length: 18 cm
- Scar width: 2.5 cm
- Total scar surface area: Approximately 45 cm² (18 cm × 2.5 cm)
Area Conversions for Affected Zones
The description states that keloid formation, hyperpigmentation, and abnormal texture each measure "less than six square inches." Converting to centimeters:
- Six square inches = 38.7 cm²
Therefore:
- Keloid formation: < 38.7 cm²
- Hyperpigmentation: < 38.7 cm²
- Abnormal texture: < 38.7 cm²
Clinical Context
This represents a linear hypertrophic or keloid scar on the right hip with multiple concerning features despite the relatively limited extent of each complication. The 18 cm length classifies this as a large scar 1, and the presence of keloid formation—even when limited to less than 38.7 cm²—indicates pathological scarring that extends beyond normal wound boundaries 2.
Key Clinical Features Present
- Tenderness (suggesting active inflammation or nerve involvement)
- Keloid formation (abnormal fibroproliferative response) 3
- Hyperpigmentation (common in darker skin types with keloids) 4
- Abnormal texture (indicating dermal remodeling)
Important Absent Features
The absence of ulceration, adherence, instability, tissue loss, active inflammation, and edema suggests this is a mature scar with keloid transformation rather than an acute or unstable process 5.
Treatment Implications
Given the keloid component, this scar would benefit from multimodal management. First-line treatment should combine intralesional triamcinolone acetonide with 5-fluorouracil for established keloid tissue 3, 6. The linear configuration and hip location (relatively low-tension area) make this amenable to intralesional therapy without immediate need for surgical excision 7.
For the hyperpigmentation component, particularly important if the patient has darker skin (Fitzpatrick IV-VI), avoid aggressive laser therapy initially due to risk of worsening pigmentary changes 4. Silicone-based therapy can be added as adjunctive prevention of further keloid expansion 3.